Asthma study: ARO-RAGE
Official title Study of Inhaled ARO-RAGE in Allergen-induced Mild Asthma
ClinicalTrials.gov ID: NCT07241546
What this study is testing
What is ARO-RAGE?
ARO-RAGE is an investigational inhaled medication being studied for asthma.
Plain-language explanation of the investigational treatment. It is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The study wants to find out whether inhaling ARO‑RAGE affects the late asthmatic response after an inhaled allergen challenge.
- Who it's for
- It is looking for people who have mild atopic asthma.
- What's involved
- Participants will inhale ARO‑RAGE and then be exposed to an allergen to see how their lungs react.
- Phase 2: a mid-size study of how well it works
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65
You may be able to join if
- Clinically stable, mild atopic asthma (FEV1 ≥70% predicted)
- Established allergy confirmed by positive skin prick test at screening
- Willing and able to perform lung function tests and other study-related procedures
- Participants of childbearing potential must consent to use a method of highly-effective contraception in addition to a condom during the study and...
You likely can't join if
- Concomitant diagnosis of a clinically important pulmonary disease other than asthma
- Use of corticosteroids, immunosuppressives, or anti-inflammatory medications that interfere with inhaled challenges or inflammation, or chronic use...
- History or current medical condition contraindicating methacholine challenge Note: Additional inclusion/exclusion criteria may apply per protocol.
The study team makes the final eligibility decision.
Where it is enrolling
- Vancouver, British Columbia, Canada
- Calgary, Canada
- Edmonton, Canada
- Hamilton, Canada
- Québec, Canada
- Saskatoon, Canada
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Vancouver, British Columbia, Canada; Calgary, Canada; Edmonton, Canada; Hamilton, Canada; Québec, Canada; Saskatoon, Canada. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.